Please login to the form below

Not currently logged in
Email:
Password:

prescription drugs

This page shows the latest prescription drugs news and features for those working in and with pharma, biotech and healthcare.

FDA clears Sandoz and Pear’s Opioid Use Disorder app

FDA clears Sandoz and Pear’s Opioid Use Disorder app

therapies, be that prescription medications or street drugs. ... Corey McCann, President and CEO of Pear Therapeutics, said: “Nearly 50, 000 drug overdose deaths involving opioids, including prescription pain medications and heroin, took place in the

Latest news

  • Reference price bill tabled in US House and Senate Reference price bill tabled in US House and Senate

    Former US presidential candidate Bernie Sanders has introduced a bill in the Senate that would peg US prescription drugs cost at no more than the median price of medicines in Canada, ... A few days later, Pfizer said that it would raise the prices of 41

  • Malthus’ orphans Malthus’ orphans

    Malthus came to mind this week as I read a valuable report from EvaluatePharma, which predicts that orphan drugs will capture no less than 20% of spend on prescription drugs by ... By and large, rare diseases and orphan drugs don’t lend themselves to

  • Trump attempts The Art of the Deal with pharma Trump attempts The Art of the Deal with pharma

    The plan seeks to increase competition, improve negotiation and create incentives to lower list prices of prescription drugs and out-of-pocket costs for consumers. ... controls and therefore pay less for drugs than Americans, while US companies invest in

  • Drugs for rare diseases will help propel pharma sales to $1.2trn by 2024; report Drugs for rare diseases will help propel pharma sales to $1.2trn by 2024; report

    That assertion ties in with its new report on worldwide prescription drug sales, which says that drugs for orphan diseases will outperform the overall pharma market, almost doubling to reach a ... That will also be a factor for orphan drugs, with recent

  • Novartis plans digital therapeutics for schizophrenia and MS Novartis plans digital therapeutics for schizophrenia and MS

    Novartis shares our vision for prescription digital therapeutics that work alongside drugs to deliver superior patient outcomes. ... The company’s Reset substance abuse app last year become the first FDA-approved prescription digital therapeutic to be

More from news
Approximately 2 fully matching, plus 165 partially matching documents found.

Latest Intelligence

  • Behaviour change – a missing ingredient? Behaviour change – a missing ingredient?

    There is plenty of evidence to show that some things are bad for us: smoking, too much sugar, alcohol and drugs, for example.So why is it that some of us ... For example, providing prescription drugs in different colours to encourage adherence, or

  • US health reforms US health reforms

    In a very real way, the cost of drugs in US - the only developed nation without some form of cost control - can affect the global marketplace. ... Several studies have shown that the United States spends considerably more per capita on prescription drugs

  • Re-awakening the emotion in healthcare communications Re-awakening the emotion in healthcare communications

    phrases. For healthcare companies, it was the same. However, it started to change when the ABPI established the Prescription Medicines Code of Practice Authority (PMCPA) in 1993 to operate the Code ... At the time, they knew the campaign would test the

  • Market access in Europe: balancing access and affordability Market access in Europe: balancing access and affordability

    The accompanying figure summarises the measures that target spending on prescription drugs. ... Governments have typically begun by exploring opportunities to negotiate lower prices for orphan drugs.

  • Deal Watch September 2016 Deal Watch September 2016

    India's Sun Pharmaceutical has partnered with Mitsubishi Tanabe Pharma to distribute and market 14 prescription drugs in Japan that Sun recently acquired from Novartis. ... 500. GSK / Aspen. Asset acquisition. Sale of anaesthetic drugs [Ultiva, Nimbex,

More from intelligence
Approximately 0 fully matching, plus 26 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Dovetail

About Dovetail We’re award-winning specialists in healthcare collaboration that makes patients’ lives better. Combining expertise with a passion for collaboration,...

Latest intelligence

Alzheimer’s disease – is Europe prepared if a breakthrough treatment becomes available?
Healthcare leaders in the European Union should begin preparing for a breakthrough now...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again - in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics